The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action
Open accessAbstract
Glucocorticoid (GC) usage is the most common non-traumatic cause of osteonecrosis of the femoral head (ON). Despite the strong association of GC with ON, the underlying mechanisms have been unclear. Investigators have proposed both direct and indirect effects of GC on cells. Indirect and direct mechanisms remain intimately related and often result in positive feedback loops to potentiate the disease processes. However, the direct effects, in particular apoptosis, have recently been shown to be increasingly important. Suppression of osteoblast and osteoclast precursor production, increased apoptosis of osteoblasts and osteocytes, prolongation of the lifespan of osteoclasts and apoptosis of endothelial cells (EC) are all direct effects of GC usage. Elevated blood pressure through several pathways may raise the risk of clot formation. High-dose GC also decreases tissue plasminogen activator activity (t-PA) and increases plasma plasminogen activator inhibitor-1 (PAI-1) antigen levels increasing the procoagulant potential of GC. Inhibited angiogenesis, altered bone repair and nitric oxide metabolism can also result. Also, GC treatment modulates other vasoactive mediators such as endothelin-1, noradrenalin and bradykinin. Thus, GCs act as a regulator of local blood flow by modulating vascular responsiveness to vasoactive substances. Vasoconstriction induced in intraosseous femoral head arteries causes femoral head ischemia. GCs also cause ischemia through increased intraosseous pressure, which subsequently decreases the blood flow to the femoral head by apoptosis of ECs as well as elevating the level of adipogenesis and fat hypertrophy in the bone marrow. It is difficult to predict which patients receiving a specific dose of GC will develop ON, indicating individual differences in steroid sensitivity and the potential of additional mechanisms. The textbook model of ON is a multiple hit theory in which, with a greater number of risk factors, the risk of ON increases. While more effort is needed to better comprehend the role of GC in ON, newer data on GC action upon the endothelial cell and the regional endothelial bed dysfunction theory sheds new light on particular GC mechanisms. Better understanding of GC pathomechanisms can lead to better treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“These changes were accompanied by diminished bone formation and turnover and impaired osteoblastogenesis and osteoclastogenesis [32] .”
BackgroundPathogenesis and natural history of osteonecrosis
Assouline-Dayan, Y. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.3202094 · Cited by 817
O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Vascular-Bed–Specific Hemostasis and Hypercoagulable States
Rosenberg, R. D., & Aird, W. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905203402007 · Cited by 569
Zangari, M., Anaissie, E., Barlogie, B., Badros, A., Desikan, R., Gopal, A. V., Morris, C., Toor, A., Siegel, E., Fink, L., et al. (2001) · Blood · doi:10.1182/blood.v98.5.1614 · Cited by 491
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip1
Weinstein, R. S., Nicholas, R. W., & Manolagas, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6714 · Cited by 378
Iuchi, T., Akaike, M., Mitsui, T., Ohshima, Y., Shintani, Y., Azuma, H., & Matsumoto, T. (2003) · Circulation Research · doi:10.1161/01.res.0000050588.35034.3c · Cited by 357
Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose
Minneci, P. C., Deans, K. J., Banks, S. M., Eichacker, P. Q., & Natanson, C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00014 · Cited by 354
Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip
Weinstein, R. S. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2907 · Cited by 313
Pathophysiology and natural history of avascular necrosis of bone
Lafforgue, P. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.01.025 · Cited by 298
Felson, D., & Anderson, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92870-4 · Cited by 267
Lymphocyte Apoptosis: Mediation by Increased Type 3 Inositol 1,4,5-Trisphosphate Receptor
Khan, A. A., Soloski, M. J., Sharp, A. H., Schilling, G., Sabatini, D. M., Li, S.-H., Ross, C. A., & Snyder, S. H. (1996) · Science · doi:10.1126/science.273.5274.503 · Cited by 259
Hypofibrinolysis, Thrombophilia, Osteonecrosis
Glueck, C. J., Freiberg, R. A., Fontaine, R. N., Tracy, T., & Wang, P. (2001) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200105000-00004 · Cited by 211
Steroid-Induced Adipogenesis in a Pluripotential Cell Line from Bone Marrow*
CUI, Q., WANG, G.-J., & BALIAN, G. (1997) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199707000-00012 · Cited by 197
Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid Treatment
Koo, K.-H., Kim, R., Kim, Y.-S., Ahn, I.-O., Cho, S.-H., Song, H.-R., Park, Y.-S., Kim, H., & Wang, G.-J. (2002) · Clinical Rheumatology · doi:10.1007/s100670200078 · Cited by 194
Procoagulants and osteonecrosis.
Jones, L. C., Mont, M. A., Le, T. B., Petri, M., Hungerford, D. S., Wang, P., & Glueck, C. J. (2003) · PubMed · Cited by 186
Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral Head
Liu, Y.-F., Chen, W.-M., Lin, Y.-F., Yang, R.-C., Lin, M.-W., Li, L.-H., Chang, Y.-H., Jou, Y.-S., Lin, P.-Y., Su, J.-S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042480 · Cited by 185
Avascular Necrosis of the Femoral Head: Vascular Hypotheses
Kerachian, M. A., Harvey, E. J., Cournoyer, D., Chow, T. Y. K., & Séguin, C. (2006) · Endothelium · doi:10.1080/10623320600904211 · Cited by 183
Self-citationGlucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis
Dempster, D., Moonga, B., Stein, L., Horbert, W., & Antakly, T. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540397 · Cited by 180
Apoptosis – a significant cause of bone cell death in osteonecrosis of the femoral head
Calder, J. D. F., Buttery, L., Revell, P. A., Pearse, M., & Polak, J. M. (2004) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.86b8.14834 · Cited by 178
Miyanishi, K., Yamamoto, T., Irisa, T., Yamashita, A., Jingushi, S., Noguchi, Y., & Iwamoto, Y. (2002) · Bone · doi:10.1016/s8756-3282(01)00663-9 · Cited by 177
Glucocorticoid Receptors and Inhibition of Bone Cell Growth in Primary Culture12
CHEN, T. L., ARONOW, L., & FELDMAN, D. (1977) · Endocrinology · doi:10.1210/endo-100-3-619 · Cited by 165
Steroid effects on osteogenesis through mesenchymal cell gene expression
Li, X. J., Jin, L., Cui, Q., Wang, G., & Balian, G. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1649-7 · Cited by 152
Boss, J. H., & Misselevich, I. (2003) · Veterinary Pathology · doi:10.1354/vp.40-4-345 · Cited by 144
Osteonecrosis in HIV: A Case-Control Study
Scribner, A. N., Troia-Cancio, P. V., Cox, B. A., Marcantonio, D. R., Hamid, F., Keiser, P. H., Levi, M. E., Allen, B., Murphy, K., Jones, R. E., et al. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200009010-00003 · Cited by 130
Hypofibrinolysis: A common, major cause of osteonecrosis
Glueck, C. J., Freiberg, R. A., Glueck, H. I., Henderson, C., Welch, M., Tracy, T., Stroop, D. M., Hamer, T., Sosa, F., & Levy, M. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830450212 · Cited by 123
Ligand-specific glucocorticoid receptor activation in human platelets
Moraes, L. A., Paul‐Clark, M. J., Rickman, A., Flower, R. J., Goulding, N. J., & Perretti, M. (2005) · Blood · doi:10.1182/blood-2005-04-1723 · Cited by 117
Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures
Li, Y., Li, Y., & Wang, Y. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200604010-00012 · Cited by 114
Mechanisms of cortisol-induced hypertension in humans
Whitworth, J. A., Brown, M. A., Kelly, J. J. P., & Williamson, P. M. (1995) · Steroids · doi:10.1016/0039-128x(94)00033-9 · Cited by 110
Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis
Kogianni, G., Mann, V., Ebetino, F. H., NUTTALL, M. E., Nijweide, P. J., Simpson, H., & Noble, B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.048 · Cited by 110
Role of Apoptosis in Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Zalavras, C. G., Shah, S., Birnbaum, M. J., & Frenkel, B. (2003) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v13.i24.140 · Cited by 106
Arteriolar rarefaction in the conjunctiva of human essential hypertensives
Harper, R. N., Moore, M. A., Marr, M. C., et al. (1978) · Microvascular Research · doi:10.1016/0026-2862(78)90070-5 · Cited by 98
Regulation of endothelial cell apoptosis in atherothrombosis
Dimmeler, S., Haendeler, J., & Zeiher, A. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00009 · Cited by 91
Chan, M. H. M., Chan, P. K. S., Griffith, J. F., Chan, I. H. S., Lit, L. C. W., Wong, C. K., Antonio, G. E., Liu, E. Y. M., Hui, D. S. C., Suen, M. W. M., et al. (2006) · Pathology · doi:10.1080/00313020600696231 · Cited by 83
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis
Gu, G., Hentunen, T. A., Nars, M., Härkönen, P. L., & Väänänen, H. K. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1893-0 · Cited by 83
Microvascular Endothelial Cell Death and Rarefaction in the Glucocorticoid-Induced Hypertensive Rat
Vogt, C., & Schmid‐Schönbein, G. W. (2001) · Microcirculation · doi:10.1111/j.1549-8719.2001.tb00163.x · Cited by 72
Talamo, G., Angtuaco, E., Walker, R. C., Li, D., Miceli, M. H., Zangari, M., Tricot, G. J. K., Barlogie, B., & Anaissie, E. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.676 · Cited by 70
Liesegang, P., Romalo, G., Sudmann, M., WOLF, L., & Schweikert, H. (1994) · Journal of Andrology · doi:10.1002/j.1939-4640.1994.tb00430.x · Cited by 69
Liesegang, P., Romalo, G., Sudmann, M., Wolf, L., & Schweikert, H. (1994) · PubMed · Cited by 67
Pluripotential Marrow Cells Produce Adipocytes when Transplanted into Steroid-Treated Mice
Cup, Q., Wang, G., & Balian, G. (2000) · Connective Tissue Research · doi:10.3109/03008200009005641 · Cited by 60
Osteonecrosis in stroke-prone spontaneously hypertensive rats: effect of glucocorticoid
Murata, M., Kumagai, K., Miyata, N., Osaki, M., & Shindo, H. (2007) · Journal of Orthopaedic Science · doi:10.1007/s00776-007-1129-y · Cited by 57
Chen, W., Lin, C., Yao, C. J., Huang, Y.-H., Chou, Y., Yin, H., & Hu, F. (2006) · Ocular Immunology and Inflammation · doi:10.1080/09273940600732380 · Cited by 55
Microvascular Endothelial Cell Death and Rarefaction in the Glucocorticoid-Induced Hypertensive Rat
Vogt, C., & Schmid‐Schönbein, G. W. (2001) · Microcirculation · doi:10.1080/713774024 · Cited by 53
Bejar, J., Peled, E., & Boss, J. H. (2005) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-2-24 · Cited by 50
Steroid Receptors in Osteoblasts
YOSHIOKA, T., Sato, B., Matsumoto, K., & Ono, K. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198005000-00047 · Cited by 49
Cao, Y., Yang, S., Du, J., Li, J., Xu, W., & Xiong, Y. (2003) · PubMed · Cited by 45
Conaway, H. H., Grigorie, D., & Lerner, U. H. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111008 · Cited by 42
Chen, W.-M., Liu, Y.-F., Lin, M.-W., Chen, I.-C., Lin, P.-Y., Lin, G.-L., Jou, Y., Lin, Y., Fann, C., Wu, J.-Y., et al. (2004) · American Journal of Human Genetics · doi:10.1086/422702 · Cited by 41
Cushing's Disease Presenting with Avascular Necrosis of the Hip: An Orthopedic Emergency
Koch, C. A., Tsigos, C., Patronas, N. J., & Papanicolaou, D. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3010 · Cited by 40
Cytochemical Demonstration of the Glucocorticoid Receptor in Skeletal Cells of the Rat
Silvestrini, G., Mccetti, P., Ballanti, P., et al. (1999) · Endocrine Research · doi:10.1080/07435809909066134 · Cited by 32
Osteogenic Gene Expression Decreases in Stromal Cells of Patients with Osteonecrosis
Chang, J., Ho, M., Yeh, C.-H., Chen, C., & Wang, G. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000238869.99980.b2 · Cited by 28
Results of a questionnaire about the Acta Orthopaedica Belgica among BVOT members.
L, D. S. (1999) · PubMed · Cited by 28
Yamamoto, Y., Ishizu, A., Ikeda, H., Otsuka, N., & Yoshiki, T. (2004) · Pathobiology · doi:10.1159/000081724 · Cited by 26
[The effects of glucocorticoids on angiogenesis in vitro].
Harada, I. (1992) · PubMed · Cited by 17
Osteonecrosis in a Patient with Crohn's Disease Unrelated to Corticosteroid Use
Khan, A. T., Iliffe, G. D., Houston, D. S., & Bernstein, C. N. (2001) · Canadian Journal of Gastroenterology · doi:10.1155/2001/293059 · Cited by 13
Rajashree, S., & Puvanakrishnan, R. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006991009036 · Cited by 10
Apoptosis in glucocorticoid-induced bone disease
Weinstein, R. S., & Manolagas, S. C. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000162075.95591.9b · Cited by 9
Cited by
The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis
Chang, C., Greenspan, A., & Gershwin, M. E. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102460 · Cited by 269
Bioglass incorporated methacrylated collagen bioactive ink for 3D printing of bone tissue
Kajave, N. S., Schmitt, T., Nguyen, T.-U., Gaharwar, A. K., & Kishore, V. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abc744 · Cited by 46
Metadata
- Authors
- Kerachian, M. A., Séguin, C., & Harvey, E. J.
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 114
- Issue
- 3-5
- Pages
- 121-128
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W2093798143
- Cited by
- 349
- References
- 58
- FWCI
- 13.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.